| Lymph node dissection during robot-assisted radical prostatectomy: Where do we stand? - Abstract |
|
|
|
|
|
| Friday, 24 July 2009 | ||
|
Department of Surgery, Division of Urology, University of California, San Diego, Medical Center, San Diego, CA, USA. Division of Urologic Oncology, Moores UCSD Comprehensive Cancer Center, San Diego, CA, USA; Division of Urology, San Diego Veterans Affairs Medical Center, San Diego, CA, USA. Since the initial report of robot-assisted laparoscopic prostatectomy (RALP) in 2001, the technique has gained rapid acceptance and utilization. When compared with more traditional forms of surgical intervention, there is still much debate with respect to cost, and impact on potency and continence. Less often is the focus on oncologic outcomes. Pelvic lymph node dissection (PLND) at the time of prostatectomy is an important part of the surgical intervention for prostate cancer and is currently underreported during robotic procedures. Herein, we review the current controversies on the value and extent of PLND and the status of emerging data regarding robot-assisted PLND. Written by: Reference: PubMed Abstract UroToday.com Prostate Cancer Section
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |











